BioNTech SE
LSE:0A3M
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioNTech SE
LSE:0A3M
|
DE |
|
T
|
Toro Co
SWB:TO2
|
US |
|
Publicis Groupe SA
LSE:0FQI
|
FR |
|
B
|
Banco Santander SA
WSE:SAN
|
ES |
|
A
|
ASGN Inc
F:OA2
|
US |
|
B
|
Best Buy Co Inc
XMUN:BUY
|
US |
|
Amcomri Group PLC
LSE:AMCO
|
UK |
|
I
|
Italgas SpA
F:I10
|
IT |
|
Palo Alto Networks Inc
BMV:PANW
|
US |
|
Systemair AB
LSE:0HDK
|
SE |
|
Dufry AG
SIX:DUFN
|
CH |
|
K
|
Kubota Corp
SWB:KUO1
|
JP |
|
F
|
Federal Home Loan Mortgage Corp
SWB:FHL
|
US |
|
M
|
McCormick & Company Inc
SWB:MCX
|
US |
|
Mobilezone Holding AG
SIX:MOZN
|
CH |
Wall St Price Targets
0A3M Price Targets Summary
BioNTech SE
According to Wall Street analysts, the average 1-year price target for 0A3M is 132.37 USD with a low forecast of 86.26 USD and a high forecast of 190.96 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0A3M's stock price target?
Price Target
132.37
USD
According to Wall Street analysts, the average 1-year price target for 0A3M is 132.37 USD with a low forecast of 86.26 USD and a high forecast of 190.96 USD.
What is the Revenue forecast for BioNTech SE?
Projected CAGR
-2%
Over the last 7 years, the compound annual growth rate for Revenue has been 56%. The projected CAGR for the next 3 years is -2%.
What is the Gross Profit forecast for BioNTech SE?
Projected CAGR
-11%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 55%. The projected CAGR for the next 3 years is -11%.
